期刊文献+

头孢曲松钠所致胆囊假性结石的CT影像诊断 被引量:9

CT imaging diagnosis of gallbladder pseudolithiasis caused by Ceftriaxone
下载PDF
导出
摘要 目的探讨静脉使用头孢曲松钠后产生胆囊假性结石的CT影像表现。方法回顾性分析我院22例住院病人在静脉使用头孢曲松钠后胆囊出现假性结石的CT表现。结果头孢曲松钠所致胆囊假性结石形成最早出现在用药后20小时,最迟7天,平均4天;假性结石在停药后均自行消失,消失时间最早为停药后第3天,最迟6个月,其中20例在2个星期内消失。22例中18例表现为泥沙样胆囊假性结石,占81.8%,其中1例儿童患者合并泌尿系结石;3例表现为块状假性结石;1例为石灰样胆汁样改变。结论静脉使用头孢曲松钠后会产生胆囊假性结石,停药后短期内可恢复正常,临床及影像医生应对此有所认识,以免给病人带来不必要的手术干预。 Objective To investigate the CT imaging features of gallbladder pseudolithiasis caused by the therapy of eefiriaxone. Methods The CT appearances of gallbladder pseudolithiasis in the intravenous use of Ceftriaxone in 22 cases were retrospectively analyzed. Results Gallbladder pseudo]ithiasis associated with ceftriaxone appeared earliest at 20 hours after intravenous use of Cefiriaxone, latest at seven days, average of four days. Gallbladder pseudolithiasis disappeared after cessation of therapy, pseudolithiasis disappeared earliest at three days, latest at six months, of which, 20 cases gallbladder pseudolithiasis disappeared in two weeks; 18 cases gallbladder pseudolithiasis showed sand-like calculi (accounting for 81.8 percent); one child patient developed urinary calculi; three cases appeared patchy stone; 1 case showed lime-like bile. Conclusion The use of intravenous ceftriaxone can caused gallbladder pseudolithiasis. After stopping to use for a short period , the patient can return to normal. Clinical and imaging doctors should be on high alert as not to cause unnecessary suffering and operation to patients.
出处 《岭南现代临床外科》 2009年第2期127-130,共4页 Lingnan Modern Clinics in Surgery
关键词 头孢曲松钠 胆囊结石 CT ceftriaxone gallbladder pseudolithiasis computed tomography
  • 相关文献

参考文献4

二级参考文献8

  • 1黄先会,何福果.超声对使用头孢曲松钠及停药后胆囊内沉积物变化的观察[J].中国超声诊断杂志,2006,7(3):222-224. 被引量:16
  • 2吴在德 吴肇汉主编.外科学:第6版[M].北京:人民卫生出版,2003.432.
  • 3吴在德 吴肇汉.外科学(第6版)[M].北京:人民卫生出版社,2003.456-457.
  • 4周永昌 郭万学.超声医学(第4版)[M].科学技术文献出版社,2004,4..
  • 5Schaad UB, Wedqwood-krucko J, Tschaeppeler H. Reversible ceftfiaxone-associated biliary pseudolithiasis in children. Lancet, 1988, 2 : 1411-1413.
  • 6Prince JS, Senac MO. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol, 2003, 33: 648-651.
  • 7Palanduz A, Yalcin I, Tonquc E, et al. Sonographic assessment of ceftfiaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound,2000, 28 : 166-168.
  • 8Papadopoulou F, Efremidis S, Karyda S, et al. Incidence of ceftfiaxone-associated gallbladder pseudolithiasis.Acta Paediatr, 1999, 88 : 1352-1355.

共引文献44

同被引文献73

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部